Production (Stage)
CureVac N.V.
CVAC
$5.54
-$0.035-0.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -133.69% | -3.04% | 314.92% | -1.94% | 17.90% |
| Total Depreciation and Amortization | 14.09% | -3.04% | -21.08% | 4.43% | -5.02% |
| Total Amortization of Deferred Charges | -- | -3.05% | -- | -- | -- |
| Total Other Non-Cash Items | -99.44% | -3.04% | 560.88% | -155.07% | -72.29% |
| Change in Net Operating Assets | 111.18% | 3.04% | -308.50% | 72.09% | -139.90% |
| Cash from Operations | -128.41% | -3.04% | 264.78% | 8.49% | -123.28% |
| Capital Expenditure | 83.60% | 3.04% | 12.79% | 33.31% | 63.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.68% | 2.67% | 99.49% | -28,748.68% | 94.77% |
| Cash from Investing | 82.81% | 3.04% | 59.97% | -45.89% | 64.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.42% | 0.00% | -4.56% | -3.36% | 0.73% |
| Issuance of Common Stock | -- | -- | -- | -54.74% | -- |
| Repurchase of Common Stock | -- | 0.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00% | -150.00% | -- | -- |
| Cash from Financing | 6.61% | 3.04% | -16.50% | -7.26% | 19.56% |
| Foreign Exchange rate Adjustments | -221.33% | -3.05% | 2.13% | -61.91% | 120.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.70% | -3.04% | 246.06% | 5.37% | -67.21% |